U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07459595) titled 'Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study' on March 05.
Brief Summary: In polycystic ovary syndrome (PCOS), changes in physical appearance i.e. weight gain, hirsutism, menstrual disturbances and infertility result in reduced quality-of-life. PCOS is one of the most common endocrine disorders affecting about 4% to 8% of women of reproductive age. Diagnosis is primarily clinical with Rotterdam criteria being the most commonly followed criteria, which require the presence of two out of the three criteria including oligo and/or anovulation, clinical and/or biochemical signs of hy...